Related references
Note: Only part of the references are listed.Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test
Eddy C. Hsueh et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
NCCN Molecular Testing White Paper: Effectiveness, Efficiency, and Reimbursement
Paul F. Engstrom et al.
Journal of the National Comprehensive Cancer Network (2017)
Melanoma Thickness and Survival Trends in the United States, 1989-2009
Waqas R. Shaikh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Melanoma Thickness and Survival Trends in the United States, 1989-2009
Waqas R. Shaikh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients
Adam C. Berger et al.
CURRENT MEDICAL RESEARCH AND OPINION (2016)
A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance
M. Dietel et al.
CANCER GENE THERAPY (2015)
Development of a Prognostic Genetic Signature to Predict the Metastatic Risk Associated with Cutaneous Melanoma
Pedram Gerami et al.
CLINICAL CANCER RESEARCH (2015)
More People Die from Thin Melanomas (≤1 mm) than from Thick Melanomas (>4 mm) in Queensland, Australia
David C. Whiteman et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy
Pedram Gerami et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma
D. L. Morton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Evaluation of BRAF Mutation Testing Methodologies in Formalin-Fixed, Paraffin-Embedded Cutaneous Melanomas
Johanne Lade-Keller et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Analytical Performance Verification of a Molecular Diagnostic for Cytology-Indeterminate Thyroid Nodules
P. Sean Walsh et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases
Charles M. Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group
Steven M. Teutsch et al.
GENETICS IN MEDICINE (2009)
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Analytical validation of the oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer
Maureen Cronin et al.
CLINICAL CHEMISTRY (2007)